Company Filing History:
Years Active: 2022
Title: The Innovative Work of Morin Mae Frick in Biopharmaceuticals
Introduction
Morin Mae Frick is a prominent inventor based in San Mateo, California, recognized for her significant contributions to the field of biopharmaceuticals. With two patents to her name, Frick's work focuses on developing methods and compounds aimed at combating virulent infections caused by Filoviridae viruses, such as Marburg and Ebola.
Latest Patents
Frick's recent patents detail groundbreaking methods for the preparation of ribosides. These methods involve a complex chemical synthesis process to create pharmaceutical compositions that can effectively treat infections caused by the Filoviridae family of viruses. One notable aspect of her work is a compound of Formula VIII, which is derived from a specific reaction mixture involving diverse reagents, including various coupling agents and bases. Additionally, her patents include the development of FXR (NR1H4) modulating compounds. These compounds bind to the FXR nuclear receptor and act as agonists, showcasing potential in treating various diseases through innovative binding techniques.
Career Highlights
Morin Mae Frick is currently associated with Gilead Sciences, Inc., a leading biopharmaceutical company dedicated to research and development in antiviral therapies. Her role at the company emphasizes her innovative spirit and commitment to advancing healthcare solutions through her research and patent efforts.
Collaborations
Throughout her career, Frick has collaborated with esteemed coworkers, including Steven Donald Axt and Pavel Robertovich Badalov. These collaborations highlight her involvement in a team that fosters innovation and tackles some of today's most pressing health challenges.
Conclusion
With a focus on innovative pharmaceutical compositions and methods for treating serious viral infections, Morin Mae Frick is a key figure in her field. Her ongoing work at Gilead Sciences reflects her dedication to improving medical outcomes through her inventive spirit and scientific expertise. As her career continues to evolve, the impact of her work will undoubtedly resonate within the biopharmaceutical community and beyond.